Context Therapeutics Company

Context Therapeutics is a clinical-stage biopharmaceutical company.
Technology: Immunotherapy
Industry: Longevity
Headquarters: Philadelphia, Pennsylvania, United States
Founded Date: 01-01-2015
Employees Number: 11-50
Funding Status: IPO
Total Funding: $31,250,000
Last Funding Date: 2021-12-06
Last Funding Type: Post-IPO Equity

Visit Website
https://twitter.com/context_tx
Register and Claim Ownership